Li et al. [7] reported that the LncRNA HOTTIP can promote the development of pancreatic cancer and regulate gemcitabine resistance by regulating HOXA13, while HOTTIP regulates cisplatin resistance in osteosarcoma cells by activating the Wnt/β-catenin pathway [8]. Here, HOTTIP is linked to pancreatic neoplasm.